BIONTECH SE - AMERICAN DEPOSITARY SHARES

120,21

06-января-25 15:45:00

15 мин. задержка

Акции

+4,42

+3,82%

Сегодняшний диапазон

116,07 - 121,46

ISIN

N/A

Источник

NASDAQ

Update Regarding Pfizer’s Statement on COMIRNATY-Related Write-Offs

16 окт 2023 02:00:00 Источник Nasdaq GlobeNewswire
Pfizer and BioNTech Receive Health Canada Authorization for XBB.1.5-Adapted Monovalent COVID-19 Vaccine

28 сен 2023 11:24:00 Источник Nasdaq GlobeNewswire
BioNTech and CEPI Announce Partnership to Advance mRNA Mpox Vaccine Development and Support CEPI’s 100 Days Mission

18 сен 2023 05:45:00 Источник Nasdaq GlobeNewswire
Pfizer and BioNTech Receive Positive CHMP Opinion for Omicron XBB.1.5-adapted COVID-19 Vaccine in the European Union

30 авг 2023 09:00:00 Источник Nasdaq GlobeNewswire
BioNTech Expands Management Board by Appointing James Ryan as Chief Legal Officer

14 авг 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech Announces Second Quarter 2023 Financial Results and Corporate Update

07 авг 2023 05:00:00 Источник Nasdaq GlobeNewswire
BioNTech Completes Acquisition of InstaDeep

31 июл 2023 07:00:00 Источник Nasdaq GlobeNewswire
BioNTech and OncoC4 Initiate Pivotal Phase 3 Trial of BNT316/ONC-392 Program in Metastatic NSCLC

29 июн 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech and OncoC4 Present Positive Phase 1/2 Data for Antibody Candidate BNT316/ONC-392 in Hard-to-Treat NSCLC at ASCO

02 июн 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech Announces First Quarter 2023 Financial Results and Corporate Update

08 май 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech to Report First Quarter 2023 Financial Results and Operational Update on May 8, 2023

24 апр 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech and DualityBio Form Global Strategic Partnership to Accelerate Development of Differentiated Antibody-Drug Conjugate Therapeutics for Solid Tumors

03 апр 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech Announces New ADS Repurchase Program

28 мар 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech Announces Fourth Quarter and Full Year 2022 Financial Results and Corporate Update

27 мар 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech and OncoC4 Announce Strategic Collaboration to Co-Develop and Commercialize Novel Checkpoint Antibody in Multiple Solid Tumor Indications

20 мар 2023 06:45:00 Источник Nasdaq GlobeNewswire
BioNTech to Report Full Year and Fourth Quarter 2022 Financial Results and Operational Update on March 27, 2023

13 мар 2023 06:45:00 Источник Nasdaq GlobeNewswire
BioNTech Announces Establishment of Interdisciplinary mRNA Excellence Center to Conduct Research Jointly with Scientists from Weizmann Institute of Science in Israel

01 мар 2023 07:00:00 Источник Nasdaq GlobeNewswire
BioNTech Strengthens Manufacturing Capabilities with First In-House Plasmid DNA Manufacturing Facility

02 фев 2023 05:45:00 Источник Nasdaq GlobeNewswire
BioNTech to Acquire InstaDeep to Strengthen Pioneering Position in the Field of AI-powered Drug Discovery, Design and Development

10 янв 2023 06:15:00 Источник Nasdaq GlobeNewswire
BioNTech Announces Strategic Partnership with UK Government to Provide up to 10,000 Patients with Personalized mRNA Cancer Immunotherapies by 2030

05 янв 2023 18:01:00 Источник Nasdaq GlobeNewswire

<<
<
1
2
3
>

Принимаю NetDania's website uses cookies. By continuing browsing our website, you agree to our Правила в отношении Cookies, Политика конфиденциальности and Правила и условия.